Aino Health AB (publ) (AINO.ST)
SEK 0.14
(0.0%)
SEK 0.14
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -7.52 Million SEK | 41.63% |
| 2022 | -12.25 Million SEK | -1.53% |
| 2021 | -12.08 Million SEK | -4.16% |
| 2020 | -9.95 Million SEK | 15.46% |
| 2019 | -12.63 Million SEK | 34.83% |
| 2018 | -18.74 Million SEK | 34.78% |
| 2017 | -28.94 Million SEK | -441.93% |
| 2016 | -5.48 Million SEK | -393.99% |
| 2015 | 1.86 Million SEK | 457.97% |
| 2014 | -521 Thousand SEK | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -2.09 Million SEK | 21.64% |
| 2024 Q2 | -1.03 Million SEK | 52.41% |
| 2023 Q4 | -2.72 Million SEK | -2153.72% |
| 2023 FY | - SEK | 35.34% |
| 2023 Q1 | -1.79 Million SEK | 45.36% |
| 2023 Q2 | -1.88 Million SEK | -4.67% |
| 2023 Q3 | -121 Thousand SEK | 93.57% |
| 2022 Q4 | -3.28 Million SEK | -43.69% |
| 2022 FY | - SEK | -1.53% |
| 2022 Q2 | -2.88 Million SEK | -1.59% |
| 2022 Q1 | -2.83 Million SEK | -10.53% |
| 2022 Q3 | -2.28 Million SEK | 20.52% |
| 2021 Q3 | -3.82 Million SEK | -84.11% |
| 2021 FY | - SEK | -4.16% |
| 2021 Q1 | -2.65 Million SEK | -347.62% |
| 2021 Q2 | -2.07 Million SEK | 21.83% |
| 2021 Q4 | -2.56 Million SEK | 32.92% |
| 2020 Q4 | 1.07 Million SEK | 147.04% |
| 2020 FY | - SEK | 15.46% |
| 2020 Q3 | -2.28 Million SEK | 35.24% |
| 2020 Q1 | -4.25 Million SEK | -22.67% |
| 2020 Q2 | -3.52 Million SEK | 17.29% |
| 2019 FY | - SEK | 34.83% |
| 2019 Q4 | -3.47 Million SEK | -43.61% |
| 2019 Q3 | -2.41 Million SEK | 43.1% |
| 2019 Q2 | -4.24 Million SEK | -70.33% |
| 2019 Q1 | -2.49 Million SEK | 44.04% |
| 2018 FY | - SEK | 34.78% |
| 2018 Q1 | -6.78 Million SEK | 15.75% |
| 2018 Q2 | -3.89 Million SEK | 42.51% |
| 2018 Q3 | -4.24 Million SEK | -8.82% |
| 2018 Q4 | -4.45 Million SEK | -5.04% |
| 2017 Q2 | -8.01 Million SEK | -49.07% |
| 2017 Q3 | -8.74 Million SEK | -9.12% |
| 2017 Q4 | -8.05 Million SEK | 7.98% |
| 2017 FY | - SEK | -441.93% |
| 2017 Q1 | -5.37 Million SEK | -47.91% |
| 2016 Q4 | -3.63 Million SEK | 0.0% |
| 2016 FY | - SEK | -393.99% |
| 2015 FY | - SEK | 457.97% |
| 2014 FY | - SEK | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Bonzun AB (publ) | -28.58 Million SEK | 73.661% |
| Kontigo Care AB (publ) | 1.67 Million SEK | 548.689% |
| Medhelp Care Aktiebolag (publ) | 10 Million SEK | 175.275% |
| RaySearch Laboratories AB (publ) | 405.93 Million SEK | 101.855% |
| Surgical Science Sweden AB (publ) | 246.9 Million SEK | 103.049% |